IP Verse

Dr Schon patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Dr Schon opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Dr Schon

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 16, 2025	DR SCHON
EP4097091	Solid State Forms Of Mavacamten And Process For Preparation Thereof	ASSIA CHEMICAL INDUSTRIES	Jun 17, 2025	DR SCHON
EP4041186	An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of Psoriasis	LEO PHARMA	Feb 17, 2025	DR SCHON
EP3373972	Compositions For Treating Spinal Muscular Atrophy	F HOFFMANN LA ROCHE	Dec 20, 2024	DR SCHON
EP3820625	Device For Dispensing A Fluid Product, And Method For Filling And For Plugging Same	APTAR FRANCE	Dec 12, 2024	DR SCHON
EP3626270	New Use	NOVARTIS	Jul 10, 2024	DR SCHON
EP2508188	Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate	BRISTOL MYERS SQUIBB	Feb 9, 2024	GEDEON RICHTER
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Nov 30, 2023	DR SCHON
EP3067043	Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor	NOVARTIS	Aug 24, 2023	DR SCHON
EP3770046	Driverless Transport System	FB INDUSTRY AUTOMATION	Jun 6, 2023	STRAWMAN

Top companies who are the clients of Dr Schon

Company	Total
DR SCHON	16
STRAWMAN	4
GEDEON RICHTER	2
NIPPON SHOKUBAI	1
NIPPON SHOKUBAI KABUSHIKI KAISHA	1
VISCOFAN	1
JULIUS GLATZ	1
LABORATORIOS LICONSA	1